The investment will see Waterland Private Equity become a significant majority stakeholder in imc (integrated medhealth communication group) with ambition to create a leading independent services provider in the global pharmaceutical communications and consulting outsourced services market.
Waterland will support imc to pursue an ambitious buy-and-build strategy with significant follow-on funding available to acquire high-quality pharmaceutical communications, digital and consulting agencies across the UK, North America and EMEA.
The investment will also be used to execute a series of strategic initiatives to enhance and expand imc’s existing service offering and establish market-leading digital and technology capabilities to better serve its clients and to attract further talent.
The DWF team who led the transaction consisted of partner Alasdair Outhwaite and associate Rosie Spencer.
Commenting on the investment, Dominic Graham, Senior Investment Manager at Waterland Private Equity, commented: “The DWF team provided excellent support and expertise to help ensure a successful completion under unprecedented circumstances."
Alasdair Outhwaite added "We are delighted to have advised Waterland Private Equity on the investment in imc group. We look forward to supporting our client to deliver its ambitious buy-and-build strategy."